top of page

This website was created by PV Digital

nDimensions IP

US supportive patent for VolitionRx for cancer detection

nDimensionsIP
Jan 7, 2016
1 min read

The company has been granted a US patent for its method of detecting fragments of chromosomes, known as nucleosomes, circulating in the blood, which indicates that cancer is present. The patent number is 9222937 for the “Method for Detecting Nucleosomes” and it runs to August 2032 [more].

Recent Posts

General Motors gets Indian patent related to powertrain technology

General Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...

Trademarks Office: Abandonment orders kept in abeyance

Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...

Delhi High Court: No “irreconcilable conflict” between the Competition Act and the Patents Act

The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...

Comments

bottom of page